1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Pain severity scores for intra-articular facet and transforaminal corticosteroid injections according to the baseline score
Variable and Baseline VAS Pain Score (0–100) Groups IFSI TFSI Subjects (No.) It 28 28 At 29 27 VAS% (mean) (95% CI) 20 It 53.3 (4.0–102.7) +83.4 (+132.8 to +34.0) At 41.6 (17.1–100.3) +70.6 (+128.5 to +12.7) 40 It 49.5 (16.7–82.4) +39.4 (+72.1 to +6.6) At 39.4 (0.6–78.2) +28.9 (+66.9–9.2) 60 It 45.8 (21.8–69.8) 4.6 (+17.2–26.5) At 37.2 (9.4–65.0) 12.9 (+12.0–37.8) 80 It 42.0 (11.6–72.4) 48.7 (23.3–74.0) At 35.0 (+0.3–70.4) 54.6 (25.2–84.0) 95 It 39.1 (2.7–80.9) 81.7 (46.0–117.3) At 33.4 (15.6–82.3) 86.0 (44.1–127.8)
Note:—VAS% indicates the relative difference between postintervention and baseline VAS pain scores; It, intention-to-treat analysis; At, as-treated analysis.